Russian, Georgian diplomats may meet in mid-OctoberRussian Politics & Diplomacy July 29, 18:41
Moscow, Ankara discuss construction of two lines of Turkish StreamBusiness & Economy July 29, 18:36
French lawmaker notes situation around Crimea gradually changingWorld July 29, 18:25
Some 18,000 detained in Turkey as suspects in failed coup plot — ministerWorld July 29, 18:19
Russian, US experts begin talks on situation in Syria’s Aleppo — diplomatRussian Politics & Diplomacy July 29, 18:10
Russian Defense Ministry to receive 2nd Angara rocket by yearendScience & Space July 29, 18:05
Moscow hopes Kiev heeds UN appeal for Olympic truceRussian Politics & Diplomacy July 29, 17:47
Russian defense ministry is optimistic about reaction to humanitarian operation in AleppoRussian Politics & Diplomacy July 29, 17:26
Moscow concerned with Israeli plans to build new settlements in West BankRussian Politics & Diplomacy July 29, 17:21
NOVOSIBIRSK, October 30 (Itar-Tass) - Scientists of the Institute of Clinical Immunology in the Siberian branch of the Russian Academy of Medical Sciences in Novosibirsk have developed a vaccine for the treatment of cancer, the institute's director, Professor Vladimir Kozlov, told Itar-Tass on Wednesday.
The vaccine has already successfully passed clinical tests. Currently, it is being given to patients by injection at the third and fourth stages of cancer and is reported as having increased patient lifespan more than twofold.
“We are deriving dendritic cells from the human body and loading them with tumor antigens," the scientist said. "Dendritic cells process them, then we inject the cells into the patient and they start working in the body evoking a strong immune response. That is, they are actively fighting the tumor."
The institute's creation "is not a classical vaccine, which is the means to prevent the illness", Professor Kozlov said. "In fact, it is cell therapy.”
The vaccine is counteracting several types of cancer - colorectal (bowel) cancer, breast cancer and prostate cancer - and the institute is ready to start its industrial production, Kozlov added.
He warned, however, that “one should not seek a panacea for malign tumors as they cannot be overcome with only one tool. Along with dendritic cells, there are other cells that fight cancer so all means are to be applied in complex. An immunomodulating cocktail is needed for a far-reaching effect,” Kozlov said.
Other types of therapy were to be used as well, such as chemotherapy and radiation therapy, the professor said. Treatment should vary case by case, he said, adding that the institute was already developing preventive vaccines against other illnesses, atherosclerosis among them, and that they would be presented soon.